-
The Centers for Medicare & Medicaid Services (CMS) continues to develop an infection control survey slated for use in the nation's hospitals later this year, using expert feedback and "pre-testing" results from the field to create a 42-page tool that assesses a wide breadth of program issues.
-
The Veterans Health Administration has developed best practices in handling large-scale epidemiologic look-back investigations, including finding a way to explain a potential exposure of blood-borne viruses to a large number of people who likely were not impacted by the incident.
-
-
-
Risk of Cancer in RA Patients Treated with Disease-Modifying Drugs; A Different Kind of Fish Story; Antidepressants and Auto Accidents
-
There has long been an appreciation of the risk of cognitive decline associated with chemotherapy but questions remain about the magnitude and duration of the observed deficits. In this meta-analysis of studies that included neuropsychological assessments at a minimum of 6 months after completion of breast cancer chemotherapy, definite but small deficits were found for both verbal and visuospatial capabilities.
-
Dementia and benzodiazepines; effectiveness of omega-3 fatty acid and Ginkgo biloba supplements; and FDA actions.
-
Three common medications amitripty-line, duloxetine, and pregabalin all appear equally efficacious in treating neuropathic pain from diabetic neuropathy.
-
In a prospectively followed cohort of obese, non-diabetic men and women from Sweden, individuals who underwent bariatric surgery had an 83% reduction in the risk of developing type 2 diabetes over 15 years of follow-up.
-
A modified recombinant human granulocyte colony-stimulating factor (G-CSF) has been approved by the FDA.
